Gang An

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 26

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Disease Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Sep 01 2003

China

Dr. :: Department of lymphoma

Publications

Jian Cui, Xiaoyun Li, Shuhui Deng, Chenxing Du, Huishou Fan, Wenqiang Yan, Jingyu Xu, Xiaoqing Li, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Xiaojing Wei, Xin Du, Lian Xu, Shuhua Yi, Dehui Zou, Tao Cheng, Lugui Qiu, Xin Gao, Gang An
Identification of Therapy-Induced Clonal Evolution and Resistance Pathways in Minimal Residual Clones in Multiple Myeloma through Single-Cell Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (17) (2024)
Xuehan Mao, Wenqiang Yan, David E Mery, Jiahui Liu, Huishou Fan, Jingyu Xu, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, Chenxing Du, Shuhua Yi, Frits Van Rhee, Bart Barlogie, John D Shaughnessy, Kenneth C Anderson, Fenghuang Zhan, Lugui Qiu, Gang An
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma. American journal of hematology 99 (4) (2024)
Xuehan Mao, Wenqiang Yan, David E Mery, Jiahui Liu, Huishou Fan, Jingyu Xu, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, Chenxing Du, Shuhua Yi, Frits Van Rhee, Bart Barlogie, John D Shaughnessy, Kenneth C Anderson, Fenghuang Zhan, Lugui Qiu, Gang An
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma. American journal of hematology 99 (4) (2024)
Jian Cui, Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Lingna Li, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Shuhui Deng, Weiwei Sui, Xiaojing Wei, Shuhua Yi, Dehui Zou, Lugui Qiu, Lian Xu, Gang An
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma. Leukemia 38 (6) (2024)
Jian Cui, Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Lingna Li, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Shuhui Deng, Weiwei Sui, Xiaojing Wei, Shuhua Yi, Dehui Zou, Lugui Qiu, Lian Xu, Gang An
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma. Leukemia (2024)
Jian Cui, Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Lingna Li, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Shuhui Deng, Weiwei Sui, Xiaojing Wei, Shuhua Yi, Dehui Zou, Lugui Qiu, Lian Xu, Gang An
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma. Leukemia 38 (6) (2024)
Huishou Fan, Bing Wang, Lihui Shi, Ni Pan, Wenqiang Yan, Jingyu Xu, Lixin Gong, Lingna Li, Yuntong Liu, Chenxing Du, Jian Cui, Guoqing Zhu, Shuhui Deng, Weiwei Sui, Lian Xu, Shuhua Yi, Xiaojing Wei, Dehui Zou, Xie-Qun Chen, Lugui Qiu, Gang An
Monitoring minimal residual disease in patients with multiple myeloma by targeted tracking serum M-protein using mass spectrometry (EasyM). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Xuehan Mao, Wenqiang Yan, David E Mery, Jiahui Liu, Huishou Fan, Jingyu Xu, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, Chenxing Du, Shuhua Yi, Frits Van Rhee, Bart Barlogie, John D Shaughnessy, Kenneth C Anderson, Fenghuang Zhan, Lugui Qiu, Gang An
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma. American journal of hematology (2024)
Xuehan Mao, Wenqiang Yan, David E Mery, Jiahui Liu, Huishou Fan, Jingyu Xu, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, Chenxing Du, Shuhua Yi, Frits Van Rhee, Bart Barlogie, John D Shaughnessy, Kenneth C Anderson, Fenghuang Zhan, Lugui Qiu, Gang An
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma. American journal of hematology 99 (4) (2024)
Jian Cui, Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Lingna Li, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Shuhui Deng, Weiwei Sui, Xiaojing Wei, Shuhua Yi, Dehui Zou, Lugui Qiu, Lian Xu, Gang An
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma. Leukemia 38 (6) (2024)
Xuehan Mao, Wenqiang Yan, David E Mery, Jiahui Liu, Huishou Fan, Jingyu Xu, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, Chenxing Du, Shuhua Yi, Frits Van Rhee, Bart Barlogie, John D Shaughnessy, Kenneth C Anderson, Fenghuang Zhan, Lugui Qiu, Gang An
Development and validation of an individualized and weighted Myeloma Prognostic Score System (MPSS) in patients with newly diagnosed multiple myeloma. American journal of hematology 99 (4) (2024)
Wenqiang Yan, Lihui Shi, Jingyu Xu, Lingna Li, Jian Cui, Yuntong Liu, Jieqiong Zhou, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Shuhui Deng, Xiaoqing Li, Xin Du, Lian Xu, Dehui Zou, Lugui Qiu, Xiaojing Wei, Gang An
Clinical implications of residual normal plasma cells within bone marrow across various disease stages in multiple myeloma. Leukemia (2024)
Jian Cui, Yuntong Liu, Rui Lv, Wenqiang Yan, Jingyu Xu, Lingna Li, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Shuhui Deng, Weiwei Sui, Xiaojing Wei, Shuhua Yi, Dehui Zou, Lugui Qiu, Lian Xu, Gang An
Fluorescence in situ hybridization reveals the evolutionary biology of minor clone of gain/amp(1q) in multiple myeloma. Leukemia 38 (6) (2024)
Huishou Fan, Bing Wang, Lihui Shi, Ni Pan, Wenqiang Yan, Jingyu Xu, Lixin Gong, Lingna Li, Yuntong Liu, Chenxing Du, Jian Cui, Guoqing Zhu, Shuhui Deng, Weiwei Sui, Lian Xu, Shuhua Yi, Xiaojing Wei, Dehui Zou, Xie-Qun Chen, Lugui Qiu, Gang An
Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM). Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Jian Cui, Xiaoyun Li, Shuhui Deng, Chenxing Du, Huishou Fan, Wenqiang Yan, Jingyu Xu, Xiaoqing Li, Tengteng Yu, Shuaishuai Zhang, Rui Lv, Weiwei Sui, Xiaojing Wei, Xin Du, Lian Xu, Shuhua Yi, Dehui Zou, Tao Cheng, Lugui Qiu, Xin Gao, Gang An
Identification of therapy-induced clonal evolution and resistance pathways in minimal residual clones in multiple myeloma through single-cell sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Lihui Shi, Wenqiang Yan, Jingyu Xu, Lingna Li, Jian Cui, Yuntong Liu, Chenxing Du, Tengteng Yu, Shuaishuai Zhang, Weiwei Sui, Shuhui Deng, Yan Xu, Dehui Zou, Huijun Wang, Lugui Qiu, Gang An
Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM). Annals of hematology (2023)
Jiahui Liu, Wenqiang Yan, Huishou Fan, Jingyu Xu, Lingna Li, Chenxing Du, Xue-Han Mao, Yuting Yan, Lian Xu, Weiwei Sui, Shuhui Deng, Shuhua Yi, Kenneth C Anderson, Lugui Qiu, Dehui Zou, Gang An
Clinical Benefit of Autologous Stem Cell Transplantation for Patients with Multiple Myeloma Achieving Undetectable Minimal Residual Disease after Induction Treatment. Cancer research communications 3 (9) (2023)
Huihsou Fan, Wenqiang Yan, Lingna Li, Jingyu Xu, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chenxing Du, Shuhua Yi, Dehui Zou, Lugui Qiu, Gang An
The prognostic utility of dynamic risk stratification at disease progression in patients with multiple myeloma. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Chenxing Du, Lingna Li, Huishou Fan, Xuehan Mao, Jiahui Liu, Yan Xu, Weiwei Sui, Shuhui Deng, Chengwen Li, Jiawei Zhao, Shuhua Yi, Mu Hao, Dehui Zou, Yaozhong Zhao, Lugui Qiu, Gang An
The age-dependent changes in risk weights of the prognostic factors for multiple myeloma. Hematology (Amsterdam, Netherlands) 28 (1) (2023)
Jingyu Xu, Wenqiang Yan, Huishou Fan, Jiahui Liu, Lingna Li, Chenxing Du, Shuhui Deng, Weiwei Sui, Yan Xu, Lugui Qiu, Gang An
Impact of residual tumor cells in the stem cell collection on multiple myeloma patients receiving autologous stem cell transplantation. Annals of hematology (2023)
Wenqiang Yan, Rui Lv, Jingyu Xu, Lingna Li, Jian Cui, Yuntong Liu, Chenxing Du, Yanyan Song, Weiwei Sui, Shuhui Deng, Yan Xu, Shuhua Yi, Dehui Zou, Lugui Qiu, Wenjun Li, Gang An
Adenopathy and extensive skin patch overlying a plasmacytoma (AESOP) syndrome: a case report and literature review. Annals of hematology (2023)
Jingyu Zhang, Fangming Shi, Xing Liu, Xuan Wu, Cong Hu, Jiaojiao Guo, Qin Yang, Jiliang Xia, Yanjuan He, Gang An, Lugui Qiu, Xiangling Feng, Wen Zhou
Proline promotes proliferation and drug resistance of multiple myeloma by downregulation of proline dehydrogenase. British journal of haematology (2023)
Jun Wang, Yuting Yan, Wenjie Xiong, Ge Song, Yi Wang, Jiawei Zhao, Yujiao Jia, Chengwen Li, Zhen Yu, Ying Yu, Jiawen Chen, Yang Jiao, Tingyu Wang, Rui Lv, Qinghua Li, Yueshen Ma, Wei Liu, Dehui Zou, Gang An, Qi Sun, Huijun Wang, Zhijian Xiao, Jian-Xiang Wang, Lugui Qiu, Shuhua Yi
Landscape of immunoglobulin heavy chain gene repertoire and its clinical relevance to LPL/WM. Blood advances 6 (13) (2022)
Guoqing Zhu, Xue Fu, Yansong Ren, Yansheng Wang, Shoulei Wang, Gang An
Comparative analysis of three serum-free light-chain detection systems in the diagnosis of multiple myeloma. International journal of laboratory hematology 44 (3) (2022)
Yuting Yan, Xiaoqi Qin, Jiahui Liu, Huishou Fan, Wenqiang Yan, Lanting Liu, Chenxing Du, Zhen Yu, Lian Xu, Mu Hao, Shuhui Deng, Weiwei Wei Sui, Rui Lv, Wei Liu, Qi Wang, Dehui Zou, Linping Hu, Jian-Xiang Wang, Yu-Tzu Tai, Kenneth C Anderson, Lei Zhang, Tao Cheng, Anders Zetterberg, Nikhil C Munshi, Lugui Qiu, Gang An
Clonal phylogeny and evolution of critical cytogenetic aberrations in multiple myeloma at single cell level by QM-FISH. Blood advances (2021)
Xiao-Qi Qin, Gang An, Zeng-Jun Li, Lan-Ting Liu, Yan Xu, Lin-Hua Yang, Yan-Ping Ma, Shu-Hui Deng, Wei-Wei Sui, Yu Qin, Xiao-Yan Feng, Mei-Rong Zang, Wen-Juan Yang, Yan-Ru Zhang, Shu-Hua Yi, Ting-Yu Wang, Rui Lv, De-Hui Zou, Yao-Zhong Zhao, Lu-Gui Qiu
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study. Blood advances 3 (5) (2020)

Gang An.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Gang An